A Validated LC-MS/MS Method for the Simultaneous Determination of Ticagrelor, Its Two Metabolites and Major Constituents of Tea Polyphenols in Rat Plasma and Its Application in a Pharmacokinetic Study

J Chromatogr Sci. 2021 May 20;59(6):510-520. doi: 10.1093/chromsci/bmab012.

Abstract

Ticagrelor is recommended for management of patients with acute coronary syndromes. Green tea is one of the most popular beverages in China and around the world. Their concomitant use is unavoidable. In this study, a selective and sensitive liquid chromatography-tandem mass spectrometry method for the simultaneous determination of plasma concentrations of ticagrelor, its two metabolites and four major constituents of tea polyphenols (TPs) in rats was developed for co-administration study of ticagrelor and TPs. Diazepam was used as internal standard (IS). Plasma samples were extracted employing a liquid-liquid extraction technique. Chromatographic separation was carried out on a Kinetex C18 column (2.1 × 75 mm, 2.6 μm) by gradient elution using 0.1% formic acid in water, acetonitrile and methanol. Seven analytes and IS were detected by a mass spectrometer with both positive and negative ionization by multiple reaction monitoring mode. The method was fully validated to be reliable and reproducible in accordance with food and drug administration (FDA) guidelines on bioanalytical method validation. The method was then successfully applied for pharmacokinetic study of ticagrelor, its two metabolites and four major constituents of TPs in rat plasma after oral administration of ticagrelor and tea polyphenol extracts.

Publication types

  • Validation Study

MeSH terms

  • Animals
  • Chromatography, Liquid / methods
  • Limit of Detection
  • Male
  • Platelet Aggregation Inhibitors / blood*
  • Polyphenols / blood*
  • Rats
  • Rats, Sprague-Dawley
  • Tandem Mass Spectrometry / methods*
  • Tea / chemistry
  • Ticagrelor / blood*

Substances

  • Platelet Aggregation Inhibitors
  • Polyphenols
  • Tea
  • Ticagrelor